Mainframe IPLA · Tell

Three signs your mainframe IPLA renewal is overpriced in 2026.

A mainframe IPLA renewal that looks normal on the cover page can be quietly thirty percent above market on the inside. There are three signs to read for, and they sit in the appendix where the procurement team rarely looks.

By The Negotiation Desk · Mainframe IPLA · Archetype: The Tell

Published 10 Mar 2026

The mainframe IPLA renewal in 2026 arrives in a shape that almost no procurement team in the customer organisation has the experience to read. IPLA contracts have a long tail of products inside a single agreement, a measurement framework that has been amended twice since the previous renewal, and an appendix structure that hides the most expensive components behind the most innocuous headings. A renewal that looks normal on the cover page (a single line item with a defined three year value and a defined escalator) is regularly overpriced by 18 to 34 percent against the market reference when read at the line item level inside the appendix. The procurement team that reads only the cover page closes a contract that the deal desk would have released significantly further on if the buyer had asked the right three questions. This is the tell on a mainframe IPLA renewal in 2026. Three signs, each in a different appendix, each worth between five and fourteen percent on the closed value.

This is the tell note. Read your IPLA renewal against these three signs before signature. If any two of them are present, the renewal is overpriced.

Sign one: the product mix in the bundle has drifted

The first sign is in the product mix inside the IPLA bundle. The bundle on a mainframe IPLA contract in 2026 typically carries between fourteen and thirty two named products. The list is inherited from the previous renewal. The list almost always carries products that the customer no longer uses, products that have been consolidated into other products, and products whose function has migrated to a different platform. A bundle inherited from the 2023 renewal that has not been reconciled regularly carries between four and eleven products that produce no production utilisation and that the customer cannot identify a current owner for. Each of those products carries a price line. The deal desk does not remove them at renewal because the deal desk is not paid to remove them. The customer has to ask. The ask is almost always granted because the deal desk's account plan does not require the line to remain in the bundle to hit the account team's quota.

Reading the sign: pull the bundle list from the appendix, walk it product by product against the customer's mainframe operations team, and identify every product the operations team cannot demonstrate active production use of. The reconciliation regularly removes seven to fourteen percent of the contract value, on products the customer is paying for and not using.

Sign two: the MSU and capacity reference is out of date

The second sign is in the MSU and capacity reference inside the technical appendix. The reference sets the unit count the IPLA pricing is multiplied against. The reference is inherited from the previous renewal. The reference is almost always higher than the current consumption. The reasons are structural: capacity right sizing programmes have moved workloads off the mainframe, sub capacity reporting on certain workload classes has not been updated in the contract, and the customer has often migrated workloads to a more efficient processor class without amending the entitlement reference downward.

Reading the sign: reconcile the contracted MSU and capacity reference against the actual production reference (from the customer's own SCRT reports and capacity plans, not the deal desk's recap). The variance is regularly between nine and twenty two percent. A reference rebuild against actual production state regularly closes between four and ten percent of the contract value, on capacity the customer is paying for and not using.

"The IPLA cover page is the wrong document to read. The contract value sits in the appendix. The deal desk knows it. The procurement team usually does not."Mainframe Practice Lead, The Desk

Sign three: the support uplift escalator has compounded

The third sign is in the support uplift escalator at the back of the agreement. The escalator was set at the previous renewal. The escalator has been compounding every year since. The compounding effect is rarely visible on the year four invoice because the invoice presents the escalated number as the current price, not as the previous price plus the escalator. A 6 percent escalator over three years compounds to roughly 19 percent. A 7 percent escalator over three years compounds to roughly 22 percent. The compounded effect is the actual price uplift the customer has been absorbing, and it is rarely visible to the procurement team negotiating the next renewal because the recap on the previous contract shows the year one price, not the compounded year four price.

Reading the sign: pull the year one price from the previous renewal, calculate the compounded year four price at the contracted escalator, and compare to the opening quote on the current renewal. If the opening quote is at or above the compounded year four price, the renewal is anchored on the escalator output, not on the market reference. The release on this sign is to renegotiate the escalator at the current renewal and to anchor the opening price below the compounded reference rather than at it. The release is regularly between three and eight percent on the closed value.

The numbers

Avg IPLA bundle product count (2026)14 to 32 products

Avg products in bundle with no production use4 to 11

Avg release on bundle reconciliation7% to 14%

Avg MSU and capacity reference variance vs production9% to 22%

Avg release on capacity reference rebuild4% to 10%

Avg release on escalator reanchor3% to 8%

Combined effect (2 or 3 signs present)18% to 34%

What we have seen on live deals this quarter

On a recent engagement with a regional bank in EMEA the opening IPLA quote came in at the compounded escalator reference, with a bundle that had not been reconciled since 2023 and a capacity reference that was 17 percent above the actual production reference. The three signs were all present. The closed contract landed 24 percent below the opening quote, on the same coverage, with a bundle reduced by nine products that the operations team confirmed had no production use.

On a separate engagement with a Fortune 200 insurer the opening IPLA quote looked aggressive at face. Only one of the three signs was present (the escalator was compounded but the bundle and capacity reference were already at production). The closed contract released seven percent against the opening quote, almost entirely on the escalator reanchor.

The takeaway

The IPLA renewal is overpriced if any two of the three signs are present: the bundle has drifted (products carried that are not in production use), the MSU and capacity reference is out of date, or the support uplift escalator has compounded against an anchor that the procurement team is not reading.
The three signs sit in different appendices and the deal desk is not paid to surface any of them. The customer has to ask. Each sign released on engagement regularly closes between three and fourteen percent.
The combined effect on engagements where two or three signs are present sits between 18 and 34 percent against the opening quote, on the same coverage and the same control posture.